Increased NFκ-B activity in HCT116 colorectal cancer cell line harboring TLR4 Asp299Gly variant

Iranian Journal of Allergy, Asthma and Immunology

Volumn 11, Issue 2, 2012, Pages 121-132

  Davoodi, Homa ^a   Hashemi, Seyed Reza ^b   Seow, Heng Fong ^c  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GORGAN UNIVERSITY OF AGRICULTURAL SCIENCES AND NATURAL RESOURCES   (Iran)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Colorectal cancer; Polymorphism; Toll like receptors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TOLL LIKE RECEPTOR 4; ASPARTIC ACID; CYTOKINE; GLYCINE; I KAPPA B; ISOPROTEIN; LIPOPOLYSACCHARIDE; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE 3; TLR4 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL LEVEL; CELL STRAIN HCT116; COLORECTAL CANCER; CONTROLLED STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; METABOLISM; PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TIME; UPREGULATION;

ASPARTIC ACID; BLOTTING, WESTERN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENES, REPORTER; GLYCINE; HCT116 CELLS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPOPOLYSACCHARIDES; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TRANSFECTION; UP-REGULATION;

EID: 84864873792     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Alpay HC, Etem EO, Kaygusuz I, Yüce H, Karlidag T, Keles E, et al. Evaluation of the polymorphism in the Toll-like receptor 4 (TLR4) genes of tympanosclerosis patients. Auris Nasus Larynx 2010; 37(1):29-32
2. Davoodi H, Seow HF. Variant Toll-Like Receptor4 (Asp299Gly and Thr399Ile Alleles) and Toll-Like Receptor2 (Arg753Gln and Arg677Trp Alleles) in Colorectal Cancer. Iran J Allergy Asthma Immunol 2011; 10(2):91-9.
3. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003; 85(2):85-95. (Pubitemid 36071561)
4. Bonaiuto C, McDonald PP, Rossi F, Cassatella MA. Activation of nuclear factor-κB by β-amyloid peptides and interferon- in murine microglia. J Neuroimmunol 1997; 77(1):51-6. (Pubitemid 27286376)
5. Cario E, Podolsky D. Intestinal epithelial tollerance versus in tollerance of commensals. Mol Immunol 2005; 42(8):887-93. (Pubitemid 40489012)
6. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, et al. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 2008; 14(5-6):346-52. (Pubitemid 351785708)
7. Schroder J, Schumann RR. Single Nucleotide Polymorphisms of Toll-Like Receptors and Susceptibility to Infectious Disease. Lancet infect Dis 2005; 5(3):156-64. (Pubitemid 40568671)
8. Sun J, Turner A, Xu J, Grönberg H, Isaacs W. Genetic variability in inflammation pathways and prostate cancer risk. Urol Oncol 2007; 25(3):250-9. (Pubitemid 46670748)
9. Marsik C, Jilma B, Joukhadar C, Mannhalter C, Wagner O, Endler G. The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin Chem 2005; 51(11):2178-80. (Pubitemid 41532642)
10. Arbour NC, Lorenz E, Schutte BC, Zabner JJ, Kline N, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25(2):187-91. (Pubitemid 30394990)
11. Franchimont D, Vermeire S, El-Housni H, Pierik M, Van Steen K, Gustot TE, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299Gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004; 53(7):987-92. (Pubitemid 38824157)
12. Schmidt C. Immune system's toll-like receptors have good opportunity for cancer treatment. J Natio Cancer Instit 2006; 98(9):574-5.
13. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gramnegative septic shock. Arch Intern Med 2002; 162(9):1028-32. (Pubitemid 34492532)
14. Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L. Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res 2008; 68(11):4026-30.
15. Papadimitraki ED, Bertsias GK, Boumpas DT. Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 2007; 29(4):310-8. (Pubitemid 47633153)
16. Savkovic DS, Koutsouris A, Hecht G. Activation of NF- -B in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol Cell Physiol 1997; 273(4 Pt 1):1160-7.
17. Hu J, Jacinto R, McCall C, Li L. Regulation of IL-1 receptor-associated kinases by lipopolysaccharide. J Immunol 2002; 168(8):3910-4. (Pubitemid 34298394)
18. Guha M, Mackman N. The phosphatidylinositol 3- kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem 2002; 277(35):32124-32. (Pubitemid 34969025)
19. Bowling WM, Hafenrichter DG, Flye MW, Callery MP. Endotoxin tolerance alters phospholipase C-gamma 1 and phosphatidylinositol-3-kinase expression in peritoneal macrophages. J. Surg Res 1995; 58(6):592-8.
20. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR,Visintin A, Latz E, et al. LPS- TLR4 signaling toIRF- 3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 2003; 198(7):1043-55. (Pubitemid 37248620)
21. Wang JH, Manning BJ, Wu QD, Blankson S, Bouchier- Hayes D, Redmond HP. Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. Immunol 2003; 170(2):795-804. (Pubitemid 36070531)
22. He W, Liu Q, Wang L, Chen W, Li N, Cao X. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 2007; 44(111):2850-9. (Pubitemid 46412506)
23. Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007; 19(6):652-7. (Pubitemid 350236805)
24. Haller D, Bode C, Hammes WP, Pfeifer AMA, SchiVrin EJ, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelialcell/leucocyte co-cultures. Gut 2000; 47(1):79-87. (Pubitemid 30430415)